Dexamfetamine, a regulated substance, is administered in Australia primarily for the management of Attention-Deficit/Hyperactivity Disorder (ADHD) and, less commonly , narcolepsy. Its use is strictly monitored under the Therapeutic Goods Act and requires a current prescription from an authorized med